tiprankstipranks
Syndax Pharmaceuticals Inc (SNDX)
NASDAQ:SNDX
Holding SNDX?
Track your performance easily

Syndax Pharmaceuticals (SNDX) Financial Statements

627 Followers

Syndax Pharmaceuticals Financial Overview

Syndax Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-3.631; its P/E ratio is -4.60; Syndax Pharmaceuticals is scheduled to report earnings on March 5, 2025, and the estimated EPS forecast is $-0.96. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 12.50M$ 3.50M---
Gross Profit$ 12.50M$ 3.50M---
EBIT$ -84.13M$ -68.02M$ -72.34M$ -72.41M$ -51.15M
EBITDA$ -84.12M$ -64.19M$ -72.34M$ -72.41M$ -51.14M
Net Income Common Stockholders$ -84.13M$ -68.06M$ -72.40M$ -72.47M$ -51.15M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 389.61M$ 425.10M$ 434.58M$ 570.70M$ 363.56M
Total Assets$ 425.81M$ 476.95M$ 543.03M$ 612.88M$ 399.22M
Total Debt$ 842.00K$ 1.11M$ 1.37M$ 1.61M$ 1.85M
Net Debt$ -388.76M$ -423.98M$ -433.21M$ -569.09M$ -361.71M
Total Liabilities$ 59.38M$ 42.61M$ 51.14M$ 58.68M$ 40.04M
Stockholders Equity$ 366.43M$ 434.34M$ 491.89M$ 554.20M$ 359.19M
Cash Flow-
Free Cash Flow$ -62.32M$ -71.64M$ -83.55M$ -41.35M$ -44.65M
Operating Cash Flow$ -62.32M$ -71.64M$ -83.55M$ -41.35M$ -44.65M
Investing Cash Flow$ 86.85M$ 61.75M$ -99.40M$ -16.29M$ 40.08M
Financing Cash Flow$ 3.10M$ 676.00K$ 2.17M$ 258.48M$ 1.85M
Currency in USD

Syndax Pharmaceuticals Earnings and Revenue History

Syndax Pharmaceuticals Debt to Assets

Syndax Pharmaceuticals Cash Flow

Syndax Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis